Terms: = Prostate cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Diagnosis
25 results:
1. The Value of the prostate Health Index and Derived Indexes in the diagnosis of prostate cancer with PI-RADS-3 Lesions.
Cui Y; Zhao J; Sun Y
Urol Int; 2023; 107(10-12):959-964. PubMed ID: 38011845
[TBL] [Abstract] [Full Text] [Related]
2. Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer.
Zou BZ; Wen H; Luo HJ; Luo WC; Xie QT; Zhou MT
Ir J Med Sci; 2023 Dec; 192(6):2681-2687. PubMed ID: 37414978
[TBL] [Abstract] [Full Text] [Related]
3. Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study.
Coles B; Welch CA; Motiwale RS; Teece L; Oliver-Williams C; Weston C; de Belder MA; Lambert PC; Rutherford MJ; Paley L; Kadam UT; Lawson CA; Deanfield J; Peake MD; McDonagh T; Sweeting MJ; Adlam D;
Eur Heart J Acute Cardiovasc Care; 2023 May; 12(5):315-327. PubMed ID: 36888552
[TBL] [Abstract] [Full Text] [Related]
4. PI-RADS
Yu R; Jiang KW; Bao J; Hou Y; Yi Y; Wu D; Song Y; Hu CH; Yang G; Zhang YD
Br J Cancer; 2023 Apr; 128(6):1019-1029. PubMed ID: 36599915
[TBL] [Abstract] [Full Text] [Related]
5. Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis.
Panunzio A; Barletta F; Tappero S; Cano Garcia C; Piccinelli M; Incesu RB; Law KW; Tian Z; Tafuri A; Tilki D; De Cobelli O; Chun FKH; Terrone C; Briganti A; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
J Surg Oncol; 2023 Mar; 127(4):560-567. PubMed ID: 36434748
[TBL] [Abstract] [Full Text] [Related]
6. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
7. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract] [Full Text] [Related]
8. Development and head-to-head comparison of machine-learning models to identify patients requiring prostate biopsy.
Yu S; Tao J; Dong B; Fan Y; Du H; Deng H; Cui J; Hong G; Zhang X
BMC Urol; 2021 May; 21(1):80. PubMed ID: 33993876
[TBL] [Abstract] [Full Text] [Related]
9. Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for prostate cancer (FinRSPC).
Pakarainen T; Nevalainen J; Talala K; Taari K; Raitanen J; Kujala P; Stenman UH; Tammela TLJ; Auvinen A
Cancer; 2021 Jan; 127(2):188-192. PubMed ID: 33048394
[TBL] [Abstract] [Full Text] [Related]
10. Is it worth carrying out ultrasound-magnetic resonance imaging fusion targeted biopsy on prostate Imaging Reporting and Data System score 3 prostate lesions?
Kim KH; Ku JY; Park WY; Hong SB; Kim S; Ha HK
Int J Urol; 2020 May; 27(5):431-438. PubMed ID: 32189394
[TBL] [Abstract] [Full Text] [Related]
11. Social connectedness and mortality after prostate cancer diagnosis: A prospective cohort study.
Wu Z; Nguyen NH; Wang D; Lynch BM; Hodge AM; Bassett JK; White VM; Borland R; English DR; Milne RL; Giles GG; Dugué PA
Int J Cancer; 2020 Aug; 147(3):766-776. PubMed ID: 31721182
[TBL] [Abstract] [Full Text] [Related]
12. Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancer.
Lindberg A; Talala K; Kujala P; Stenman UH; Taari K; Kilpeläinen TP; Tammela TL; Auvinen A
Int J Cancer; 2019 Aug; 145(3):632-638. PubMed ID: 30653262
[TBL] [Abstract] [Full Text] [Related]
13. Association Between Guideline-Discordant prostate cancer Imaging Rates and Health Care Service Among Veterans and Medicare Recipients.
Makarov DV; Ciprut S; Walter D; Kelly M; Gold HT; Zhou XH; Sherman SE; Braithwaite RS; Gross C; Zeliadt S
JAMA Netw Open; 2018 Aug; 1(4):e181172. PubMed ID: 30646111
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic performance of
Zhang J; Shao S; Wu P; Liu D; Yang B; Han D; Li Y; Lin X; Song W; Cao M; Zhang J; Kang F; Qin W; Wang J
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):908-920. PubMed ID: 30635755
[TBL] [Abstract] [Full Text] [Related]
15. prostate cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer.
Thibault C; Eymard JC; Birtle A; Krainer M; Baciarello G; Fléchon A; Le Moulec S; Spaeth D; Laguerre B; Caffo O; Deville JL; Beuzeboc P; Hasbini A; Gross-Goupil M; Helissey C; Bennamoun M; Hardy-Bessard AC; Oudard S
Eur J Cancer; 2018 Jul; 97():41-48. PubMed ID: 29636272
[TBL] [Abstract] [Full Text] [Related]
17. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
Eggener S
Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
[TBL] [Abstract] [Full Text] [Related]
18. [Value of magnetic resonance imaging for early diagnosis of prostatic carcinoma in central zone].
He H; Fan S; Li Y; Ke M; Li Y; Chen B; Yu H
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1051-4. PubMed ID: 24851886
[TBL] [Abstract] [Full Text] [Related]
19. Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study.
Kenfield SA; DuPre N; Richman EL; Stampfer MJ; Chan JM; Giovannucci EL
Eur Urol; 2014 May; 65(5):887-94. PubMed ID: 23962747
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y
Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266
[TBL] [Abstract] [Full Text] [Related]
[Next]
